SCHEMBL21166675

SCHEMBL21166675

c1ccc(-c2nc3cc4sc5cc6nc(-c7ccccc7)sc6cc5c4cc3s2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.58
SMN1; SMN2 Q16637 6/20 0.58
MAPT P10636 6/20 0.58
ALDH1A1 P00352 5/20 0.58
GAA P10253 5/20 0.58
HPGD P15428 4/20 0.58
PKM P14618 4/20 0.58
GLA P06280 4/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
NFKB1 P19838 7/20 0.55
NFKB2 Q00653 7/20 0.55
RELA Q04206 7/20 0.55
LMNA P02545 3/20 0.55
RAB9A P51151 10/20 0.49
NPC1 O15118 9/20 0.49
STAT1 P42224 1/20 0.49
APP P05067 3/20 0.46
POLB P06746 3/20 0.45
TP53 P04637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3187010 0.91 KDM4E (0.68) KDM4ESMN1; SMN2MAPTALDH1A1GAA
SCHEMBL15773556 0.87 KDM4E (0.48) KDM4ESMN1; SMN2MAPTALDH1A1GAA
SCHEMBL17404415 0.85 KDM4E (0.66) KDM4ESMN1; SMN2MAPTALDH1A1GAA
SCHEMBL16203571 0.83 SMN1; SMN2 (0.49) KDM4ESMN1; SMN2MAPTALDH1A1GAA
SCHEMBL26746755 0.83 KDM4E (0.64) KDM4ESMN1; SMN2MAPTALDH1A1GAA
SCHEMBL24466846 0.81 KDM4E (0.62) KDM4ESMN1; SMN2MAPTALDH1A1GAA
SCHEMBL26745122 0.81 KDM4E (0.62) KDM4ESMN1; SMN2MAPTALDH1A1GAA
SCHEMBL23954265 0.81 KDM4E (0.54) KDM4ESMN1; SMN2MAPTALDH1A1GAA
SCHEMBL14193958 0.81 SMN1; SMN2 (0.58) KDM4ESMN1; SMN2MAPTALDH1A1GAA
SCHEMBL23954319 0.81 APP (0.58) KDM4ESMN1; SMN2MAPTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10985327-B2 Microcrystalline organic semiconductor film, organic semiconductor transistor, and method of manufacturing organic semiconductor transistor FUJIFILM CORPORATION (JP) 2021-04-20 US disclosed
US-20190237677-A1 MICROCRYSTALLINE ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR TRANSISTOR, AND METHOD OF MANUFACTURING ORGANIC SEMICONDUCTOR TRANSISTOR FUJIFILM CORPORATION (JP) 2019-08-01 US disclosed
US-20190221754-A1 BOTTOM GATE TYPE ORGANIC SEMICONDUCTOR TRANSISTOR FUJIFILM CORPORATION (JP) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190237677-A1 MICROCRYSTALLINE ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR TRANSISTOR, AND METHOD OF MANUFACTURING ORGANIC SEMICONDUCTOR TRANSISTOR OR10J3, ALK, MSMO1 KDM4E 2164/4885SMN1; SMN2 3981/4885MAPT 497/4885
US-10985327-B2 Microcrystalline organic semiconductor film, organic semiconductor transistor, and method of manufacturing organic semiconductor transistor OR10J3, ALK, MSMO1 KDM4E 2164/4885SMN1; SMN2 3981/4885MAPT 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.